PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM)
Clinical trial NCT01192308 · COMPLETED
Trial details
- NCT number
- NCT01192308
- Sponsor
- Radboud University Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-05-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.